When I started building in women’s health, I quickly realised something that still surprises me: endometriosis is often treated as a narrow gynaecological issue, while the literature describes something much bigger.

This is not a niche condition.

And yet, for decades, the system has behaved as if the problem was simply that women were not explaining their symptoms clearly enough.

That is not true.

The problem is not a lack of symptoms. The problem is that symptoms are often non-specific, normalised, dismissed, or misattributed. The result is a diagnostic journey that can last years. A recent systematic review found diagnostic delays ranging from 0.3 to 12 years, depending on the study and healthcare setting.

To me, that is not only a clinical problem.

It is a product problem.
It is a data problem.
It is an infrastructure problem.
And, ultimately, it is a failure of imagination.

Why the science matters

I do not believe it is helpful to say that endometriosis is “basically cancer” or “basically an autoimmune disease”. That may sound powerful, but it is not precise enough.

The stronger statement is also the more accurate one:

Endometriosis is its own disease, but it behaves in ways that resemble both.

Recent reviews have mapped endometriosis against the hallmarks of cancer and found evidence across key mechanisms such as abnormal proliferation, immune evasion, invasion, angiogenesis, resistance to apoptosis, and metabolic reprogramming.

At the same time, studies show an association between endometriosis and autoimmune disease. One large case-control study found that women with endometriosis had around twice the odds of receiving at least one autoimmune diagnosis within two years compared with matched controls.

This matters because classification shapes care.

If we keep treating endometriosis as “just painful periods”, we will keep building shallow solutions. If we recognise it as a complex, chronic, systemic condition, then we can start building the kind of infrastructure it actually requires.

The cost is not only medical

From a founder’s point of view, the burden of endometriosis is not only biological. It is operational, economic, emotional, and social.

The literature consistently shows that endometriosis is associated with reduced quality of life, repeated healthcare use, and substantial direct and indirect costs.

Longer diagnostic delays are linked to more emergency visits, more hospitalisations, and higher healthcare costs. Other reviews suggest that indirect costs may represent at least half of the total burden, reflecting lost work time, reduced productivity, and the invisible labour of managing the disease every day.

This is the part people often miss.

A chronic condition is not only symptoms. It is the work of managing symptoms.

It is planning, tracking, explaining, doubting yourself, adapting your day, cancelling things, preparing for pain, and trying to stay functional in a system that rarely captures the full picture.

That hidden work has a cost.

And today, most of that cost is carried by patients.

Why earlier identification matters

Endometriosis is difficult to diagnose partly because symptoms overlap with many other conditions.

Pain.
Fatigue.
Gastrointestinal symptoms.
Urinary symptoms.
Mood changes.
Painful sex.
Bleeding patterns.
Flare-ups.

These signals are often scattered across time, contexts, and specialists.

The healthcare system usually captures snapshots.

But chronic conditions do not happen in snapshots. They happen longitudinally, cyclically, and in real life.

That is where better infrastructure becomes essential.

If a condition has long delays, overlapping symptoms, high healthcare use, and major quality-of-life impact, then the opportunity is not only treatment. The opportunity is earlier identification, better tracking, better patient stratification, and more structured pathways to care.

This is exactly where ENDOless sits.

Why we are building ENDOless

I do not see ENDOless as “another women’s health app”.

That would be too small.

We are building a structured data layer for women’s chronic pain and endometriosis, starting from lived symptoms and translating them into evidence that can be useful for patients, clinicians, researchers, and eventually care systems.

The challenge is not that women do not have data.

Women have years of data in their bodies, calendars, notes, cancelled plans, emergency visits, pain patterns, and unanswered questions.

The challenge is that this data is fragmented, unstructured, and often never reaches the people who could use it to improve care.

ENDOless exists to close that gap.

We adapt research-based questionnaires and clinical logic into a product experience that women can actually use. We help capture symptoms over time, structure the information, and turn lived experience into something more actionable.

This is not about exaggeration. It is about seriousness.

The literature does not support exaggeration.

It supports seriousness.

Endometriosis sits at the intersection of gynaecology, immunology, oncology, chronic pain, and data science. That is part of why it has been so difficult to classify neatly, and part of why it has been underserved for so long.

But difficult does not mean niche.

Complex does not mean impossible.

And women’s pain should not have to become unbearable before the system starts paying attention.

For me, endometriosis is not a “women’s health awareness” story. It is a scientific, clinical, and commercial opportunity to build something the system has been missing for far too long: infrastructure for conditions that live outside the clinic, but shape entire lives.

That is what we are building at ENDOless.

Not because it is easy.

Because the evidence is there.
Because the need is there.
And because women deserve better than being told to wait, explain, and suffer more clearly.

Life has a strange sense of timing.

Two days ago, I was told that ENDOless would not be pitching on a small local stage.

The reason, more or less, was that the audience would not be interested. That we were not the right fit. That we were not prepared enough. That maybe women’s health, chronic pain, endometriosis, research equity, and real-world data were not the priorities in that room.

And today, I get to announce that ENDOless has been selected as one of the Top 10 startups for RAISE the STAKES 2026, the startup competition of RAISE Summit, one of the biggest AI events in Europe.

Out of more than 1,500 applicants, ENDOless will pitch at the Carrousel du Louvre.

I am proud.

Not in the polished, corporate, “happy to share” way.

I am proud in the deeply human way.

Proud because this journey is not clean.
Proud because building a startup from lived experience is not romantic most days.
Proud because being a woman founder, an immigrant, a patient, and someone trying to build in health, AI, research, and infrastructure at the same time is not exactly the easiest configuration in the founder starter pack.

And yet, here we are.

ENDOless was not born because I saw a “market opportunity” in women’s health.

It was born because I lived the problem.

I lived the pain.
I lived the diagnostic delay.
I lived the dismissal.
I lived the mental load of managing a chronic condition while trying to have a career, a life, ambition, love, dignity, and some form of stability.

And the more I listened to other women, the clearer it became: this was never only my story.

It is a systemic data problem.

Women with chronic pain generate information every day: symptoms, flares, triggers, treatment responses, behaviour patterns, hormonal changes, sleep disruption, fatigue, work impact, and emotional load.

But most of this information disappears.

It is not captured properly.
It is not structured.
It is not connected to research.
It is not used to improve care.
It is not visible enough to influence prevention, clinical decisions, pharma research, or public health.

So yes, ENDOless is about women’s health.

But it is also about infrastructure.

It is about transforming lived experience into structured, research-grade real-world evidence.
It is about helping women understand and manage their health while generating the kind of data that researchers, clinicians, pharma, and healthcare systems desperately need.
It is about making chronic pain measurable, visible, and finally actionable.

Yet, still, sometimes, we hear that it is niche. Half of the population is not a niche.

That women’s health is not a priority. It has been treated that way. That does not make it true.

That chronic pain is too specific. Pain shapes everything: work, relationships, mental health, healthcare use, and quality of life.

That endometriosis is too narrow.

That the market is complicated. Of course it is. The whole system is involved: patients, doctors, researchers, pharma, employers, insurers, and public health.

That research takes time. Then let’s stop wasting years because the right data was never collected.

That healthcare is hard. Yes. That is not an argument against building. It is the reason to build better.

All of this is true.

But “hard” is not the same as “not important”.

And “underfunded” is not the same as “small”.

Women’s health has been treated as a niche for too long, while half of the population continues to carry symptoms, delays, costs, and invisible work that our systems have failed to measure properly.

This is exactly why ENDOless exists.

So today, I am allowing myself to feel proud.

Proud of ENDOless.
Proud of the team.
Proud of every woman who trusted us with her story.
Proud of every mentor, partner, friend, investor, researcher, and supporter who did not dismiss the problem because it was complex.
Proud of the fact that even when one door closes, another one can open onto a much bigger stage.

There is something almost absurd and very beautiful in the contrast.

Two days ago: “This audience may not be interested.”

Today: “You are pitching at one of Europe’s biggest AI events.”

Life turns quickly.

But the mission stays the same.

Make women’s pain visible.
Make research possible.
Make better care inevitable.

See you at the Carrousel du Louvre.

xoxo

I thought I was building a solution for endometriosis

The more women I meet, the less certain I become that ENDOless is an endometriosis company.

Perhaps this sounds odd, considering that endometriosis is precisely where everything started. It is my story, after all.

Yet, after more than 250 user interviews and thousands of conversations, I cannot shake the feeling that we have collectively underestimated the scale of the problem. Different countries, different ages, different backgrounds, different lives; somehow, all conversations eventually lead to the same place.

I am no longer entirely convinced we are speaking solely about endometriosis. I suspect we are speaking about something much bigger. The irony is that these conversations almost always start identically.

I don't think I can help

I don't really have any symptoms.

My case isn't severe enough.

I have also started noticing a common thread. Women instinctively try to make themselves convenient. They minimise, they qualify, they apologise; almost as if asking for help required justification.

Ten minutes later, a paradox emerges.

Women tell me they have "no symptoms at all", they then proceed to describe years of cancelled plans, fainting from pain, persistent fatigue, brain fog, relationships under strain and entire lives organised around uncertainty.

What fascinates me is not the contradiction itself, but the fact that these experiences are no longer recognised as symptoms.

They have become normal.

They have become expected.

They have become life.

The second life created around a chronic condition

Perhaps the hardest part to articulate is that, over time, a chronic condition ceases to be a health issue alone and gradually becomes something around which life reorganises itself.

The shift is almost impossible to notice while it happens. It does not occur overnight, but through hundreds of small adjustments, compromises and calculations which, taken individually, seem insignificant yet, collectively, end up reshaping an entire life.

I also wonder whether we have been measuring the wrong thing all along.

Pain is easy to recognise. Everybody understands pain. Symptoms are important and, to some extent, we know how to document them.

Yet a chronic condition is far more than a collection of symptoms. It is the tremendous, and largely invisible cost of continuously managing them and, perhaps more importantly, integrating the possibility of them into everyday life.

Rarely do we stop and ask ourselves what a chronic condition truly costs.

Not because the answer is unknown, but because we have become remarkably good at measuring what is visible whilst overlooking everything else.

Pain is visible.

Symptoms are visible.

Consultations, prescriptions and surgeries are visible.

What remains largely invisible is the hidden workload generated by the condition itself: countless calculations, negotiations and adjustments that quietly accumulate until they begin to shape an entirely different way of living.

At some point, without even noticing it, a second life emerges.

A life that runs quietly alongside the visible one.

You still work.

You still travel.

You still make plans.

Yet every decision now carries an additional layer of complexity.

Every commitment is preceded by a calculation.

Every plan is accompanied by a contingency plan.

Every day begins with a negotiation:

Will I have enough energy?

Should I preserve myself today?

Can I afford to say yes?

Will my body cooperate?

The extraordinary thing is that, after a while, none of this feels extraordinary anymore.

The calculations become automatic.

The negotiations become reflexes.

The adjustments become personality traits.

Eventually, we stop recognising them as consequences of a condition at all.

Perhaps this is where we have collectively misplaced cause and effect.

We observe women functioning and conclude that they are well.

We observe women showing up and conclude that they are coping.

We observe women performing and conclude that they are resilient.

When, in reality, what we are observing is years of invisible work.

Perhaps the greatest burden of a chronic condition is not the condition itself, but the extraordinary amount of energy required to build an entire life around the possibility of it.

It simply becomes life.

Perhaps we have become too convenient

The more women I speak to, the more I notice another phenomenon.

Women do not naturally claim space.

They justify it.

They reassure me that their case is probably not severe enough, that others have it worse, that they are mostly fine.

I find this fascinating because, by the time they say these words, they have already described a life that has been profoundly shaped by their condition.

Perhaps years of adaptation have taught us to become convenient.

Convenient patients.

Convenient employees.

Convenient partners.

Convenient women.

Convenient enough not to complain too much, not to ask for too much and not to disrupt the lives of others.

I sometimes wonder whether this is another cost we have failed to measure.

Not only the burden of the condition itself, but the extraordinary amount of energy spent making sure that burden remains invisible to everyone else.

VivaTech reminded me of something important

Women have never been the barrier.

Women came to our booth to tell their stories. Some wanted to know more. Some simply wanted to say thank you. Some hugged me. Many asked me not to stop.

There is a recurring narrative suggesting that women are reluctant to share their data, that engaging them is difficult and that privacy and research cannot coexist.

I have yet to meet these women.

Not a single woman has ever told me: "No, please don't use my data."

Not once.

Some ask questions. Some want transparency. Some want to understand how their data will be protected.

Eventually, however, they almost always arrive at the same conclusion.

If this can help another woman, please use it.

Why I build ENDOless

My background in economics probably explains why I keep returning to the same thought.

There is a principle we learn very early on: ceteris paribus – all other things being equal.

The trouble is that things are almost never equal.

Not in economics.

Not in society.

Certainly not in women's health.

The more historical and medical literature I read, the more I wonder whether we have spent decades refining systems whose initial assumptions were flawed to begin with.

Perhaps we have not underestimated women's pain.

Perhaps we have underestimated women's ability to live around it.

And perhaps that is infinitely more dangerous.

Because the more invisible the burden becomes, the easier it is to convince ourselves that it no longer exists.

Building a health startup is not just about technology.

It is about navigating one of the most complex ecosystems in the world - medicine, regulation, hospitals, patients, research, and funding - all at the same time.

This is why programs like HIIT (Health Innovation Intensive Training) exist.

And today, I’m proud to share that ENDOless has been selected as one of the 24 startups chosen among more than 70 applicants to participate in the 2026 edition of the program.

The official announcement took place at MedInTechs, bringing together entrepreneurs, clinicians, investors, and leaders shaping the future of healthcare innovation.

What is the HIIT Program?

The Health Innovation Intensive Training (HIIT) program is organized by La French Tech Grand Paris and the Digital Medical Hub (AP-HP).

It aims to help promising health startups better understand the realities of building solutions inside healthcare systems.

The program is held under the High Patronage of the President of the French Republic, Emmanuel Macron, and this edition is sponsored by Dr Olivier Véran, former French Minister of Health.

HIIT brings together a small cohort of selected startups and immerses them in an intensive program designed to address the real challenges of health innovation.

Because building in healthcare is fundamentally different from building in other sectors.

A great idea is not enough.

You must understand:

• medical practice
• regulatory frameworks
• hospital systems
• patient realities
• reimbursement pathways
• and the complexity of bringing innovation into care environments

HIIT exists to help startups bridge that gap.

What We Will Work On

During the program, we will work with healthcare experts, investors, clinicians, and entrepreneurs on several key dimensions of digital health innovation.

These include:

• understanding healthcare regulations and legal frameworks
• learning how to collaborate effectively with clinicians and patients
• defining market access and funding strategies
• anticipating the transformation of healthcare through digital tools and AI

For a startup like ENDOless, these questions are not theoretical.

They determine whether innovation can actually reach patients.

Why This Matters for ENDOless

ENDOless was created to address a massive gap in women’s health.

Millions of women live with chronic gynecological pain, including conditions like endometriosis, chronic pelvic pain, and severe menstrual disorders.

Yet these conditions remain under-diagnosed, poorly understood, and significantly under-researched.

The average diagnostic delay for endometriosis alone is still estimated at 7 to 10 years.

During those years, women navigate pain, uncertainty, and often disbelief.

At ENDOless, we are building an AI-powered platform that helps women track symptoms, understand their bodies, anticipate pain patterns, and contribute to better research through real-world data.

Programs like HIIT are important because they help ensure that solutions like ours are built in collaboration with healthcare professionals, not just around them.

Innovation in healthcare only works if it connects patients, clinicians, research, and technology.

Building the Future of Women’s Health

For decades, women’s health has been underrepresented in medical research.

Pain conditions affecting women have often been minimized or misunderstood.

But things are changing.

New technologies, better data, and growing awareness are creating an opportunity to rethink how we understand and manage women’s health.

ENDOless is part of that movement.

Our goal is simple:

to make women’s pain visible, measurable, and finally taken seriously - for women themselves, for healthcare providers, and for medical research.

A Community of Health Innovators

Being selected for HIIT also means joining a community of entrepreneurs working to transform healthcare.

These founders are building solutions across diagnostics, digital therapeutics, AI, hospital infrastructure, and patient care.

And while our missions may differ, we share the same ambition:

to build tools that improve how healthcare works in the real world.

Looking Ahead

Participating in HIIT is not just a milestone for ENDOless.

It is an opportunity to challenge our assumptions, refine our strategy, and strengthen our collaboration with the healthcare ecosystem.

Because real innovation in health doesn’t happen alone.

It happens when patients, doctors, researchers, entrepreneurs, and institutions work together.

We’re grateful to La French Tech Grand Paris, Digital Medical Hub, and everyone involved in making this program possible.

And we’re excited for what comes next

We’re proud to share that ENDOless has been selected for the 2026 Mapping of French AI Startups, conducted by France Digitale with the support of Sopra Steria Ventures.

This annual mapping highlights 1,114 French startups that place artificial intelligence at the core of their mission — using technology to create impact across industries, with a strong French and European footprint.

Being part of this mapping is an important milestone for ENDOless.
Not because of visibility alone — but because it confirms that AI for women’s health belongs fully in the deep-tech conversation.

Why this recognition matters

Artificial intelligence is often associated with finance, logistics, cybersecurity, or industrial optimisation.
Women’s health — and especially chronic pain — is still too often treated as a secondary topic.

Yet chronic pain affects millions of women, remains under-researched, under-measured, and frequently dismissed.

ENDOless was built to change that.

By combining:

• AI-powered symptom tracking
• real-world, longitudinal data
• and a privacy-first approach

we aim to make women’s chronic pain visible, measurable, and actionable — for women themselves, for care teams, and for research.

This recognition by France Digitale places ENDOless within a broader ecosystem of AI startups working on real, structural challenges, and helps reinforce the legitimacy of women’s health as a field deserving serious technological investment.

AI for women’s health: a necessary shift

At ENDOless, AI is not about automation for its own sake.

It’s about:

• understanding patterns that are invisible at a single point in time
• capturing lived experience beyond short medical appointments
• and contributing to research that reflects real lives, not averages

Women’s pain has long been minimised partly because it has been poorly measured.
AI, when used responsibly, can help close that gap.

Being featured in this mapping is a signal that this approach — combining technology, care, and research — is both relevant and necessary.

Thank you

We thank France Digitale and Sopra Steria Ventures for highlighting the diversity, ambition, and depth of the French AI ecosystem — and for giving space to projects that tackle complex, long-overlooked challenges.

We’re proud to represent AI for women’s health within this ecosystem, and we remain committed to building tools that support women, care systems, and research — ethically, rigorously, and with purpose.

👉 Explore the full mapping (in French):
https://francedigitale.org/publications/mapping-startups-ia-2026

Endometriosis is not a trend.
It is not a lifestyle condition.
And it is not a niche women’s issue.

It is one of the most prevalent chronic diseases affecting women worldwide - and one of the least measured.

Endometriosis is a chronic, systemic inflammatory disease that affects an estimated 1 in 10 women worldwide — nearly 190 million people (World Health Organization).

Yet despite its prevalence, endometriosis remains one of the most delayed, misunderstood, and under-measured conditions in modern medicine.

I didn’t start working on endometriosis because it was a good market opportunity.
I did it because living with it – and listening to thousands of women – makes one thing painfully clear:

The problem isn’t awareness.
The problem is how poorly women’s pain is structured, measured, and trusted - in clinics, in data, and in society.

This article explains the medical basics of endometriosis and the systemic failures around it – and also why better tools and data are no longer optional.

What is endometriosis – and why I care so deeply about explaining it well

Endometriosis – often called "endo" – is not “just bad periods”. It is a chronic condition that quietly rearranges your life around pain, fatigue, and uncertainty.

In simple terms, it happens when tissue similar to the uterine lining (endometrium) grows outside the uterus, in places where it doesn’t belong. Each month, this tissue reacts to hormones like a period would – but unlike a period, it has nowhere to go.

So it stays.
It inflames.
It scars.
It hurts.

Over time, that hurt can become many things at once: pain that comes and goes, pain that settles in and refuses to leave, and a level of exhaustion that no amount of sleep can touch. You wake up tired. You go to bed tired. In between, you’re trying to be “fine” for everyone else.

I care about explaining this clearly because I know how disorienting endometriosis can be – not only in the body, but in the mind.

When your pain is irregular, invisible, and hard to describe, you start turning the doubt inward
Maybe I’m exaggerating.
Maybe everyone feels this and just copes better.
Maybe it’s in my head.

I did that. For a long time.
And I’ve met countless women who did the same – ambitious, capable, responsible women silently reorganising their entire lives around pain while still performing, still smiling, still showing up.

Endometriosis is not just about periods. It can show up:

• outside the menstrual cycle
• during ovulation
• during or after sex
• when eating or digesting
• when sitting, standing, walking – or simply existing in your body

Some days are “manageable”: you negotiate with your pain, you plan your day around it, you adapt.
Other days, it quietly takes everything out of you – your concentration, your patience, your joy – and from the outside, nothing looks “serious” enough to justify how bad you feel.

There is no cast, no visible wound, no dramatic moment. Instead, there are cancelled plans, rearranged careers, postponed dreams, and a constant mental calculation:

If I say yes to this, what will it cost my body later?

This is why I am so demanding about the way we talk about endometriosis.

Words shape reality.

They influence how doctors listen, how workplaces respond, how families support, and how policymakers prioritise.

When we reduce endo to “painful periods”, we erase the people who can’t sit through a meeting, can’t stand upright in the shower, can’t enjoy sex without pain, or whose fertility, work, and relationships are deeply affected.

For me, explaining endometriosis well is not a branding exercise or an awareness slogan. It is a responsibility.

Because understanding what endometriosis really is – in simple, honest, non-dramatic terms – is the first step toward being believed.

And being heard changes everything: it shapes how quickly you are diagnosed, what treatment pathways are open to you, what accommodations you feel legitimate asking for, and how you speak to yourself when your body sets limits you never chose.

Why diagnosis is still so difficult

Endometriosis is notoriously hard to diagnose.

• Blood tests are unreliable
• Ultrasounds often miss lesions
• MRI can help, but is not definitive
• Surgery remains the gold standard – and is invasive

Most medical appointments capture snapshots, not patterns.

Pain that comes and goes is easy to minimise.
Data that doesn’t exist can’t be used.

Up to 50% of women with chronic pelvic pain have endometriosis
– The Lancet

This is not a failure of individual doctors.
It is a systemic failure of continuity, data, and context.

Endometriosis doesn’t only affect health.
It affects lives.

Women with endometriosis are 50% more likely to reduce or leave work
– Harvard T.H. Chan School of Public Health

On average, women lose 10+ workdays per year
– World Economic Forum / McKinsey Health Institute

Globally, endometriosis costs the economy ≈ $280 billion per year
in healthcare expenses and lost productivity
– The Lancet Global Health

Behind those numbers are quiet stories:
careers slowed, ambitions postponed, confidence eroded.

Many women are forced – implicitly or explicitly – to choose between their health and their lives.

We should never have to make that choice.

There is no simple solution – and that’s the hardest truth

Some people are given pills.
Some are advised to have surgery.
Sometimes it helps.
Sometimes it doesn’t.
And often, it helps for a while – then stops.

What I've learnt the hard way is this:
Endometriosis is not something you “fix” once and move on from.

Two women with the same diagnosis can live completely different realities.
What eases pain for one can make things worse for another.
What works this year may not work next year.

Care often feels like trial and error – and that uncertainty is exhausting.

Not because women aren’t trying hard enough.
But because the condition itself is complex.

Why I built ENDOless

I built ENDOless because I got tired of feeling like I had to prove my pain.

Not to replace care.
Not to promise miracles.

But to help women make their experience visible – over time, in their own words, at their own pace.

Because being believed should not depend on how well you summarise your life in 15 minutes.

One last thing

If you’re reading this and recognising yourself:
you’re not exaggerating.
you’re not weak.
and you’re not alone.

Endometriosis is real.
Women’s pain is real.

And we deserve systems that actually listen.

That’s why ENDOless exists.

ENDOless was never meant to be “just an app.”

It’s a movement to make women’s health visible, measurable, and impossible to ignore — in medicine, in research, and in society.

Today, we’re opening a new way to stand behind that mission.
Our ENDOless Membership Tiers are now live.

This isn’t a subscription.
It’s a way to help build what doesn’t exist yet

Why We Created Membership

Women’s health is still underfunded, under-measured, and too often built without the people it’s meant to serve in the room.

We didn’t want to build ENDOless behind closed doors.

Membership allows our community to:

• Support ethical, privacy-first health technology
• Help fund research-grade data infrastructure, not just content or marketing
• Influence how a platform for chronic, cyclical, and invisible conditions is actually designed

Every tier contributes to:

• AI development for symptom prediction and flare-up modeling
• Secure, consent-based data systems for research and clinical use
• Keeping ENDOless accessible — not locked behind high-priced healthcare tools

The Four Ways to Be Part of This

We designed our tiers to reflect different ways of showing up for the mission, not different levels of importance.

🫶 Community Ally — Free

A place to belong, follow, and stay connected.

For those who want to:

• Follow ENDOless as it grows
• Access public updates and shared resources
• Be part of a community where women’s pain is taken seriously

This tier exists because access should never be a barrier to visibility.

💜 Supporting Member — €5 / month

A way to support the mission — and get closer to what we’re building.

For those who want:

• Members-only posts with community insights, reflections, and learnings
• Early access to announcements, pilots, and studies
• Private newsletter sections on what we’re building, why, and what’s blocking us
• A voice in discussions around women’s health innovation

This tier helps fund the work behind the scenes — not just the product you’ll one day see.

✨ Inner Circle — €20 / month

For those who want proximity, dialogue, and a real voice in shaping ENDOless.

This includes everything above, plus:

• Private strategy posts — including doubts, trade-offs, and decisions
• Invitations to live sessions (monthly or quarterly)
• The ability to influence direction through polls, feedback, and votes
• First access to experiments, tools, and pilots

This tier exists for people who don’t just want to follow the journey —
they want to help steer it.

🌟 Super Believer — €100 / month

For those who choose to actively support ENDOless’s growth, impact, and independence.

Everything above, plus:

• Annual merch package (1 shipment per year)
• Your name on our Wall of Believers (opt-in)
• A Super Believer badge in the app
• The ability to gift one Supporting Membership per year
• Occasional private founder updates

This tier is about backing the mission at a structural level, not just cheering from the sidelines.

What Your Support Actually Builds

When you join a tier, you’re helping us create:

🧠 A Living Health Intelligence System
AI that understands cycles, patterns, and long-term health — not just daily check-ins.

🔬 Ethical Research Infrastructure
Real-world data shared only with consent and scientific purpose.

🛡️ Privacy-First Technology
GDPR-by-design systems where women always control their data.

🌍 Access Over Exclusivity
A future where women’s health tools aren’t reserved for those who can afford premium care.

This Is Bigger Than a Platform

Membership isn’t about content.
It’s about leverage.

Leverage to push women’s health into research agendas.
Leverage to design better care systems.
Leverage to turn lived experience into data that changes how medicine works

If you’ve ever felt invisible in a system that wasn’t built for you —
this is a way to help change that.

👉 Choose your tier
👉 Support the mission
👉 Help shape what comes next

Because the future of women’s health shouldn’t be built without women in the room.

Join the ENDOless Community

This week, ENDOless won the Prix de l’Entrepreneuriat au Féminin at the Made in 92 demi-finale, organized by Grand Paris Seine Ouest.

Let me say this first:
I’m grateful. I’m proud. And I showed up fully for that moment.

Now let me say the part people don’t always like.

I didn’t win the competition.
I won the category.

And that difference matters more than we’re willing to admit.

The Trophy and the Ceiling

When my name was called, I was the only woman awarded that night.
In the women’s category.

It’s a celebration.
It’s also a boundary.

Because ENDOless is not a “women’s project.”
It’s AI.
It’s health data infrastructure.
It’s regulatory-grade evidence pipelines, research systems, and clinical-facing technology.

We don’t compete for symbolism.
We compete for market dominance, scientific legitimacy, and institutional adoption.

So here’s the uncomfortable question I carried home with me:

Do I want to be exceptional inside a box — or competitive in the real arena?

The Line That Never Left Me

As a child, I watched a cartoon about musketeer dogs.
One sentence burned itself into my memory:

“Do you want to be the best of the worst… or the worst of the best?”

I’ve always wanted to stand with the best — even if it means losing, learning, and fighting my way back up.

Because that’s where real companies are built.
Not in categories.
In markets.

Let’s Talk About the System, Not the Feelings

In France today:

• ~30% of founders are women
• Less than 10% of venture capital funding goes to female-founded startups
• In AI and deep tech, that number often falls below 5%
• Women-led startups are more likely to win awards and grants
• They are significantly less likely to close growth rounds

What does that mean in practice?

Women are often celebrated.
Men are often financed.

Credit Where It’s Due

Let me be clear about something else.

That room was not full of “projects.”
It was full of builders.

Women who are turning craft into brands, care into companies, and conviction into real economic value.

I want to name a few of them — because none of us should be climbing alone:

• Ma Face Gym — transforming facial fitness into a structured, accessible wellness practice
• Lait Sauvage — uniting ethical sourcing, gastronomy, and entrepreneurship
• Pousses et Plantes — bringing sustainable cultivation and local ecosystems to everyday life
• Ycao — blending creativity, craftsmanship, and commercial ambition

These founders aren’t competing for a category.
They’re competing in the economy.

And they deserve to be seen that way.

Why This Award Still Matters

This demi-finale win isn’t a finish line.

It’s a signal flare.

It says:
“You’re visible now. The real test starts here.”

Because the next rooms I want ENDOless in are not asking:

“How does it feel to be a woman founder?”

They’re asking:

“How defensible is your data?”
“How fast can you scale across health systems?”
“What makes your AI clinically and regulatorily unavoidable?”
“Why will institutions choose you over global platforms?”

That’s the game I’m training for.

Gratitude — and a Promise

To Grand Paris Seine Ouest and Made in 92: thank you for putting ENDOless on that stage. I don’t take that lightly.

But I didn’t start this company to win a category.

I started it to help build health infrastructure that Europe can’t afford to ignore.

So yes — I’ll take the trophy.

And then I’ll take my seat in the harder room.

The one where there are no labels.
No special lanes.
No symbolic wins.

Only competition, capital, and impact.

That’s where ENDOless is going.

For the curious — this is the cartoon that planted that line in my head all those years ago:
Pup in boots (1981) — the musketeer dogs who taught me, very early, that the real fight is always in the main arena.

When you’re building a startup, you go through many firsts.

Some are exciting.
Some are terrifying.
All of them shape you.

A few days ago, I lived another one: my first time on TV.

I was invited on B SMART 4Change to present ENDOless and the work we’re doing to change how women’s health is understood, measured, and treated.

It may sound like a milestone.
In reality, it was something quieter — and heavier.

Why this first mattered

I didn’t grow up dreaming of being on television.
I didn’t build ENDOless to be visible.

I built it because women’s pain is still invisible — in medicine, in data, in research, and in professional life.

That’s why I was deeply proud that this first TV appearance happened in France, on a channel that makes space for conversations about care, innovation, and impact — not just growth or performance.

Because women’s health doesn’t need more noise.
It needs seriousness.

Going on TV is not about exposure

Going on TV isn’t about exposure for me.
It’s about carrying a voice.

The voice of women who wait years for a diagnosis.
The voice of women whose pain is questioned, normalised, or dismissed.
The voice of women who slowly leave their careers — not because they lack ambition, but because their bodies no longer fit rigid systems.

It’s the voice of women who are forced — implicitly or explicitly — to choose between their health and their lives.

Women should never have to make that choice.

Speaking as a founder — and as a woman

I didn’t go on TV to share a personal story alone.
I went to explain why this keeps happening.

Why diagnostic delays persist.
Why women’s pain is still under-measured.
Why care systems struggle when data is fragmented, episodic, or biased.

ENDOless exists because lived experience and data should not be separated.
Because women deserve tools that help them be believed — by themselves, by clinicians, and by research.

I’m grateful to Hervé Bonnaud and Alix Nguyen for the quality of their questions, for listening, and for treating women’s health as a serious topic — not a side note.

And I’m grateful to B SMART 4Change for creating spaces where these conversations can exist with nuance and respect.

Visibility comes with responsibility.
Once you speak publicly, you don’t just represent yourself.

You carry others with you.

Why ENDOless keeps going

ENDOless doesn’t exist for headlines.
It doesn’t exist for vanity metrics.

It exists because giving up is not an option.
Not when the need is this real.
Not when the silence has lasted this long.

ENDOless exists for women.
Across ages, countries, cultures, and beliefs.
For women navigating pain, work, care, and uncertainty — often at the same time.

Women’s pain is real.
Women’s lives matter.
And access to care should never be a privilege.

🎤 🎬You can watch the TV segment here:

We are launching soon.
And no matter how hard this journey gets —
we keep going.

Instead of gifts, I’m asking you to support an association.
Not just any.

Today, I want to highlight Girls & Tech, founded by Gwenaëlle Bailly and Elise Dufour.

Because this association didn’t just “support a project”.
It changed my trajectory.

Thanks to Girls & Tech, I was able to go to Las Vegas, present ENDOless, meet extraordinary people, and — maybe most importantly — confirm something deep inside me:

👉 The choices I made were right.
👉 What we’re building matters.
👉 Women do belong on those stages.

In France, donations to associations like Girls & Tech are tax-deductible, which means your support goes further than you think.
For me, it will directly help ENDOless cover part of our costs and keep building a better, fairer healthcare system.

This year… was hard.

It’s hard to build something meaningful without the right people around you.
It’s hard to keep going when relationships fall apart.
It’s hard to divorce.
It’s hard to hold a vision when everything around you feels unstable.
It’s hard not to give up — especially when you’re tired, doubting yourself, and still showing up.

Some thoughts from this year, unfiltered:

• It was lonely
• It was heavy
• It required more courage than I expected
• And I didn’t quit

If I had to sum it up in one sentence, I’d say:
“Not bad.”

And if donating to an association isn’t possible for you right now, there’s also my personal Revolut cagnotte.
Every euro collected there goes entirely to ENDOless’ concrete needs — nothing else.

This birthday isn’t about me.
It’s about collective momentum, women supporting women, and choosing the world we want to build.

Thank you for being part of it 🤍

Alexandra